AdaptHealth Corp. $AHCO Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC reduced its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 61.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 109,108 shares of the company’s stock after selling 171,206 shares during the quarter. Intech Investment Management LLC’s holdings in AdaptHealth were worth $977,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Invesco Ltd. boosted its holdings in AdaptHealth by 50.0% during the second quarter. Invesco Ltd. now owns 1,906,074 shares of the company’s stock worth $17,974,000 after buying an additional 634,973 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of AdaptHealth by 82.9% in the second quarter. Ameriprise Financial Inc. now owns 1,123,834 shares of the company’s stock valued at $10,598,000 after buying an additional 509,255 shares in the last quarter. Lazard Asset Management LLC lifted its position in shares of AdaptHealth by 1,246.3% during the 2nd quarter. Lazard Asset Management LLC now owns 686,720 shares of the company’s stock valued at $6,474,000 after acquiring an additional 635,713 shares during the last quarter. CSM Advisors LLC acquired a new stake in shares of AdaptHealth during the 2nd quarter valued at $6,149,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of AdaptHealth by 60.3% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 644,332 shares of the company’s stock worth $6,076,000 after acquiring an additional 242,347 shares in the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AHCO has been the topic of a number of recent analyst reports. Leerink Partners cut their target price on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating on the stock in a research report on Thursday, February 26th. Weiss Ratings cut AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research note on Wednesday, February 25th. Royal Bank Of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a report on Wednesday, February 25th. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Finally, Wall Street Zen cut shares of AdaptHealth from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $13.25.

AdaptHealth Stock Down 1.1%

NASDAQ:AHCO opened at $9.49 on Monday. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of -17.25, a PEG ratio of 1.09 and a beta of 1.76. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.17. The company has a current ratio of 1.02, a quick ratio of 0.81 and a debt-to-equity ratio of 1.15. The business’s fifty day moving average price is $10.11 and its 200 day moving average price is $9.66.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, February 24th. The company reported ($0.76) earnings per share for the quarter, missing the consensus estimate of $0.34 by ($1.10). The business had revenue of $846.29 million for the quarter, compared to analysts’ expectations of $832.51 million. AdaptHealth had a negative net margin of 2.18% and a positive return on equity of 3.42%. The company’s revenue was down 1.2% compared to the same quarter last year. During the same period last year, the firm earned $0.34 EPS. On average, sell-side analysts forecast that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.